等待开盘 11-17 09:30:00 美东时间
-0.100
-3.70%
The latest update is out from Sunshine Biopharma ( ($SBFM) ). On October 13, 20...
10-15 04:30
Sunshine Biopharma ( ($SBFM) ) has provided an update. On October 8, 2026, Suns...
10-10 05:49
Sunshine Biopharma (SBFM) on Thursday announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the company expected to be about $6 million. The offerin...
10-08 20:17
Launch introduces ondansetron 4 mg and 8 mg tablets for nausea and vomiting associated with chemotherapy, radiation therapy and surgery Global ondansetron market projected to reach $2.98 billion by 2034, up from $1.82 billion in 2025, according to DataIntelo Commercial rollout supported by Nora Phar...
09-24 21:02
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826007193/sunshine_8k.htm https://www.sec.gov/Archives/edgar/data/1402328/000168316826007195/sunshine_pre14c.htm
09-17 04:17
Sunshine Biopharma ( ($SBFM) ) has provided an update. As of the date of the fi...
09-12 05:27
Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company offering and researching life-saving medicines across multiple therapeutic areas including oncology and antivirals, today provided an update and outlined next plans for its oncology project, the K1.1 mRNA lipid n...
08-26 21:03
Sunshine Biopharma Inc. (NASDAQ:SBFM) on Wednesday released an update regarding its proprietary oncology initiative, outlining key next steps for its K1.1 mRNA lipid nanoparticle program. K1.1 mRNA Preclinical Results The K1.1 mRNA gene acts as a tumor suppressor frequently mutated in hepatocellular...
08-26 20:31
Global anti-hypertensive drug market projected to reach $37.24 billion by 2034 Enalapril is a widely prescribed ACE inhibitor used to treat hypertension, heart failure and left ventricular dysfunction Sunshine Biopharma expects Enalapril tablets in four dosage strengths to begin shipping to Canadian...
08-19 21:02
Sunshine Biopharma Inc. (NASDAQ:SBFM) announced on Wednesday that it has secured regulatory approval to introduce its generic Enalapril tablets across the Canadian market, signaling a significant strategic step into first-line antihypertensive treatments. The newly approved medication, the generic e...
08-19 20:30